Brief: MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease

MYND Life Sciences

27/10/2021 13:20

Oct 27 (Reuters) - MYND Life Sciences Inc  MYND.CD :
    * MYND LIFE SCIENCES SIGNS AGREEMENT TO ACQUIRE RIGHTS FOR
THE USE
OF PSYCHEDELICS TO TREAT ALZHEIMER'S DISEASE AND OTHER DEMENTIAS

Source text for Eikon:  ID:nCNW3R7hJa 
Further company coverage:  MYND.CD 

 ((Reuters.Briefs@thomsonreuters.com;))